Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spero Therapeutics (SPRO) Restructuring Costs (2022 - 2025)

Historic Restructuring Costs for Spero Therapeutics (SPRO) over the last 3 years, with Q2 2025 value amounting to $83000.0.

  • Spero Therapeutics' Restructuring Costs changed N/A to $83000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $877000.0 for FY2024, which is N/A changed from last year.
  • Per Spero Therapeutics' latest filing, its Restructuring Costs stood at $83000.0 for Q2 2025.
  • In the past 5 years, Spero Therapeutics' Restructuring Costs ranged from a high of $11.8 million in Q2 2022 and a low of -$152000.0 during Q3 2022
  • Over the past 3 years, Spero Therapeutics' median Restructuring Costs value was $129000.0 (recorded in 2025), while the average stood at $2.1 million.